NEFL and Dravet syndrome: Likewise, plasma neurofilament light (NfL), and IL1β, have been shown in multiple studies to reliably distinguish DSAD individuals with DS asymptomatic for AD (aDS) (Petersen and O’Bryant, 2019; Startin et al., 2019; McGlinchey et al., 2020).